Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,768 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00739063 | Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast Cancer | terminated | Phase 2 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00515788 | DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis | terminated | Phase 1 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00412542 | Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas | completed | Phase 2 | 78 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00506857 | Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support | completed | Phase 1 / Phase 2 | 82 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00831493 | Vorinostat Plus Radiation Therapy in Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00113347 | Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT00378781 | Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 24, 2012 | clinicaltrials |
| NCT00460395 | Surgery Versus Stereotactic Radiosurgery in the Treatment of Single Brain Metastasis: A Randomized Trial | completed | Phase 3 | 64 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 24, 2012 | clinicaltrials |
| NCT00488553 | Molecular Epidemiology of Lymphoma Patients | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 24, 2012 | clinicaltrials |
| NCT00059605 | Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer | completed | Phase 1 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00003564 | Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas | withdrawn | Phase 3 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 22, 2012 | clinicaltrials |
| NCT00003599 | Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer | withdrawn | Phase 3 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 22, 2012 | clinicaltrials |
| NCT00003714 | Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 22, 2012 | clinicaltrials |
| NCT00037843 | Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening | completed | Phase 3 | 114 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 22, 2012 | clinicaltrials |
| NCT00074750 | Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML) | terminated | Phase 1 | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 22, 2012 | clinicaltrials |
| NCT00502814 | 3-Dimensional Form and Soft Tissue Biomechanics of the Breast | terminated | — | 45 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 22, 2012 | clinicaltrials |
| NCT01003626 | Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 22, 2012 | clinicaltrials |
| NCT00005969 | Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 20, 2012 | clinicaltrials |
| NCT00489632 | Children's Resiliency, Adjustment, and Coping | completed | — | 66 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 20, 2012 | clinicaltrials |
| NCT00493181 | Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients | completed | Phase 2 | 8 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 20, 2012 | clinicaltrials |
| NCT00890656 | Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage | completed | Phase 2 | 90 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 20, 2012 | clinicaltrials |
| NCT01082939 | Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) | completed | Phase 2 | 80 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 20, 2012 | clinicaltrials |
| NCT01189513 | SCH-900105 in Recurrent Glioblastoma | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 20, 2012 | clinicaltrials |
| NCT00068575 | Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | completed | Phase 2 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00430014 | Study of Atiprimod Treatment for Patients With Advanced Cancer | terminated | Phase 1 | 28 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | completed | Phase 3 | 273 | M.D. Anderson Cancer CenterOTHER | 4 | Feb 14, 2012 | clinicaltrials |
| NCT00411593 | Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC) | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 8, 2012 | clinicaltrials |
| NCT00493129 | Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) | completed | Phase 2 | 8 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 8, 2012 | clinicaltrials |
| NCT00526032 | Melanoma Detection by Oblique-Incidence Optical Spectroscopy | completed | — | 490 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 31, 2012 | clinicaltrials |
| NCT01409187 | IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jan 26, 2012 | clinicaltrials |
| NCT00042250 | IUdR/BUdR Cell Cycle Labelling | completed | N/A | 28 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 24, 2012 | clinicaltrials |
| NCT00423709 | Allogeneic Blood Stem Cell Transplantation | completed | N/A | 46 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 24, 2012 | clinicaltrials |
| NCT00088231 | PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP | completed | Phase 1 / Phase 2 | 9 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00427765 | Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma | completed | Phase 2 | 168 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00508456 | Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM | terminated | Phase 1 | 18 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT00526331 | Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | completed | Phase 4 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT00504660 | 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients | completed | Phase 2 | 75 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 11, 2012 | clinicaltrials |
| NCT01083589 | Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 11, 2012 | clinicaltrials |
| NCT00561912 | Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma | terminated | Phase 2 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 26, 2011 | clinicaltrials |
| NCT00473551 | Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies | terminated | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 19, 2011 | clinicaltrials |
| NCT00735618 | Relaxation and Heart Rate Variability | completed | N/A | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 19, 2011 | clinicaltrials |
| NCT00423436 | Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) Patients | completed | N/A | 84 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 16, 2011 | clinicaltrials |
| NCT00533169 | ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma | terminated | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 15, 2011 | clinicaltrials |
| NCT00002882 | Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma | completed | Phase 3 | 140 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT01462383 | The Role of the EKG in Anticancer Drug Development | completed | — | 525 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 12, 2011 | clinicaltrials |
| NCT00790452 | Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 8, 2011 | clinicaltrials |
| NCT00410865 | Wild Type p53 Adenovirus for Oral Premalignancies | terminated | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00525876 | Non-Myeloablative Allogeneic Stem Cell Transplantation | completed | N/A | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00113841 | Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma | completed | N/A | 42 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 23, 2011 | clinicaltrials |
| NCT00429117 | Interest in Spirituality and Oncology: Is It An International Phenomenon? | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Nov 18, 2011 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials